Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PFE

Pfizer Inc.

Apr 16 • 02:18PM ET

25.76

Dollar change -0.15
Percentage change -0.56	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO SCHD IVV VTV VYM VHT IWD MOAT DVY

Scroll to Statements

Index	S&P 500	P/E	71.69	EPS (ttm)	0.36	Insider Own	0.04%	Shs Outstand	5.65B	Perf Week	-3.79%
Market Cap	145.49B	Forward P/E	9.40	EPS next Y	2.74	Insider Trans	0.13%	Shs Float	5.64B	Perf Month	-7.78%
Income	2.13B	PEG	-	EPS next Q	0.54	Inst Own	70.12%	Short Float	1.15%	Perf Quarter	-9.02%
Sales	58.50B	P/S	2.49	EPS this Y	20.69%	Inst Trans	0.52%	Short Ratio	1.51	Perf Half Y	-19.76%
Book/sh	15.77	P/B	1.63	EPS next Y	23.37%	ROA	1.01%	Short Interest	65.00M	Perf Year	-37.45%
Cash/sh	2.25	P/C	11.46	EPS next 5Y	-1.33%	ROE	2.31%	52W Range	25.61 - 41.33	Perf YTD	-10.51%
Dividend Est.	1.70 (6.59%)	P/FCF	30.35	EPS past 5Y	-27.43%	ROI	1.39%	52W High	-37.66%	Beta	0.62
Dividend TTM	1.65 (6.40%)	Quick Ratio	0.69	Sales past 5Y	10.96%	Gross Margin	48.99%	52W Low	0.61%	ATR (14)	0.49
Dividend Ex-Date	Jan 25, 2024	Current Ratio	0.91	EPS Y/Y TTM	-93.20%	Oper. Margin	6.16%	RSI (14)	30.30	Volatility	1.86% 1.63%
Employees	88000	Debt/Eq	0.84	Sales Y/Y TTM	-41.70%	Profit Margin	3.65%	Recom	2.27	Target Price	31.22
Option/Short	Yes / Yes	LT Debt/Eq	0.72	EPS Q/Q	-168.11%	Payout	439.41%	Rel Volume	0.50	Prev Close	25.91
Sales Surprise	-0.84%	EPS Surprise	163.21%	Sales Q/Q	-41.34%	Earnings	May 01 BMO	Avg Volume	43.01M	Price	25.76
SMA20	-4.96%	SMA50	-5.38%	SMA200	-16.77%	Trades		Volume	16,177,557	Change	-0.56%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60
Nov-18-22	Initiated	Credit Suisse	Outperform	$55
May-23-22	Initiated	SVB Leerink	Mkt Perform	$55
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$55
Jan-05-22	Upgrade	BofA Securities	Neutral → Buy	$59 → $70
Jan-03-22	Reiterated	Bernstein	Mkt Perform	$44 → $65

Show Previous Ratings

Today 01:49PM	Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff (Benzinga)
05:05AM	UPDATE 1-Evonik beats market expectations with Q1 core profit (Reuters)
Apr-15-24 05:45PM	Why the Market Dipped But Pfizer (PFE) Gained Today (Zacks)
08:45AM	Is Pfizer Stock a Buy? (Motley Fool)
04:53AM	Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks. (Motley Fool)
03:00PM	Loading…
Apr-14-24 03:00PM	10 Micro-Cap Healthcare Stocks Insiders Are Buying (Insider Monkey)
03:00AM	Large Fund Bets Big on Groceries in the Face of Persistent Inflation (Barrons.com)
Apr-13-24 12:18PM	Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024 (Insider Monkey)
10:00AM	Two Brothers, a Big Biotech Bet and an $8 Billion Payout (The Wall Street Journal)
05:47AM	The Smartest Dividend Stocks to Buy With $400 Right Now (Motley Fool)
Apr-12-24 06:30PM	Big Pharma: Investment Bedrock (Barrons.com)
06:07AM	2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever (Motley Fool)
05:50AM	Is Pfizer Stock the Biggest Bargain in the S&P 500? (Motley Fool)
05:00AM	Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up (Quartz)
Apr-11-24 10:00AM	Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25 (Business Wire)
09:53AM	Loading…
09:53AM	4 Key Takeaways From CEO Andy Jassy's Letter to Amazon Shareholders (Investopedia)
09:12AM	Will Pfizer's (PFE) New Drugs Provide a Boost to 2024 Sales? (Zacks)
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
12:47PM	The Pharmaceutical Industry Finds Itself At A Historical Crossroads (Benzinga)
11:43AM	Is Pfizer Stock A Sell As Shares Hit A Fresh Low Amid The Search For Its Next Big Break? (Investor's Business Daily)
09:26AM	Pfizer's (PFE) RSV Vaccine Study in Adults Under 60 Meets Goal (Zacks)
02:06AM	Where Will Pfizer Stock Be in 10 Years? (Motley Fool)
Apr-09-24 05:14PM	Pfizer unveils positive phase 3 trial results for RSV vaccine (Yahoo Finance Video)
12:49PM	Pfizer wants the first FDA approval ever for an RSV vaccine for young adults (Quartz)
10:54AM	Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For All Adults. (Barrons.com)
08:15AM	2 Ultra-High-Yield Dividend Stocks to Buy and Hold Forever (Motley Fool)
08:10AM	Pfizer, with new study results, seeks to bring RSV shot to adults aged 18-59 (BioPharma Dive)
07:02AM	Pfizer to Ask FDA to Extend RSV Shot Approval to All Adults (Barrons.com)
06:47AM	Pfizer RSV shot meets goals in trial of high-risk adults under age 60 (Reuters)
06:45AM	Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO in Adults Aged 18 to 59 at Increased Risk for RSV Disease (Business Wire)
05:50AM	Loading…
05:50AM	Billionaire Ken Griffin Loaded Up on This High-Yield Dividend Stock. Should You? (Motley Fool)
Apr-08-24 05:57PM	20 Most Populated Counties in the US (Insider Monkey)
05:45PM	Pfizer (PFE) Declines More Than Market: Some Information for Investors (Zacks)
12:44PM	ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager (PR Newswire)
09:00AM	Is Trending Stock Pfizer Inc. (PFE) a Buy Now? (Zacks)
05:47AM	This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market (Motley Fool)
05:06AM	Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead (Motley Fool)
Apr-07-24 05:47AM	My Top-5 Ultrahigh-Yield Dividend Stocks to Buy in April (Motley Fool)
Apr-06-24 06:49AM	3 No-Brainer Dividend Stocks to Buy in April (Motley Fool)
Apr-05-24 02:16PM	Final Trades: Pfizer, Alphabet and Amazon (CNBC TV)
06:12AM	3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income (Motley Fool)
Apr-04-24 09:27AM	Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript (Insider Monkey)
04:05AM	Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake. (Barrons.com)
Apr-02-24 10:22AM	Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:21AM	3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screamings Buys in April (Motley Fool)
Apr-01-24 05:45PM	Pfizer (PFE) Stock Moves -0.11%: What You Should Know (Zacks)
02:49PM	US scientists are leaving academia. Thats bad news for drug companies (CNN Business)
10:15AM	2 Stocks Down 30% and 27% to Buy and Hold (Motley Fool)
07:56AM	5 FDA decisions to watch in the second quarter (BioPharma Dive)
05:05AM	Better Recovery Story Buy: Pfizer vs Moderna (Motley Fool)
Mar-31-24 09:31AM	Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why. (Motley Fool)
Mar-30-24 03:52PM	11 Oversold Blue Chip Stocks to Buy Right Now (Insider Monkey)
Mar-29-24 11:04PM	20 Countries with the Highest Age Dependency Ratio in the World (Insider Monkey)
Mar-28-24 07:03PM	Morningstar unveils 10 cheap stocks with big moats (TheStreet)
05:28PM	BetterInvesting Magazine Update on Paychex Inc. and Pfizer Inc. (PR Newswire)
02:36PM	20 Best Stocks to Buy Right Now According to Financial Media (Insider Monkey)
01:38PM	Calls of the Day: Bank of America, Oracle, Abbvie and Pfizer (CNBC TV)
10:06AM	Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 09:25AM	TipRanks Perfect 10 List: These 3 Top-Scoring Stocks Are Sending a Bullish Signal (TipRanks)
09:00AM	Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now? (Zacks)
08:20AM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
04:50AM	3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000 (Motley Fool)
Mar-26-24 05:12PM	After terminating 1 of 2 late-stage sickle cell disease trials, Pfizer still expects FDA approval in 2026 (FierceBiotech.com)
02:47PM	SEC Tests Insider-Trading Theory at Trial of Ex-Biotech Executive (Bloomberg)
08:36AM	Moleculin Biotech, Inc. (NASDAQ:MBRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:18AM	UPDATE 1-China to speed up 'new productive forces', vice president says (Reuters)
06:18AM	25 Countries with the Highest Death Rate From Malnutrition (Insider Monkey)
04:17AM	2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever (Motley Fool)
Mar-25-24 05:45PM	Pfizer (PFE) Gains As Market Dips: What You Should Know (Zacks)
09:48AM	German industry sceptical of China's vow to treat foreign firms equally (Reuters)
06:47AM	UPDATE 2-BioNTech gets US agency notice over default on COVID vaccine royalties (Reuters)
06:25AM	Novo Nordisk and Eli Lilly May Finally Have Some Real Competition (Motley Fool)
05:51AM	3 Ultra-High-Yield Dividend Stocks That Could Realistically Double Your Money by 2030 (Motley Fool)
04:50AM	Cathie Wood Is Selling This High-Yield Dividend Stock. Should You? (Motley Fool)
Mar-24-24 10:42AM	16 Most Undervalued Large Cap Stocks To Buy According To Analysts (Insider Monkey)
Mar-23-24 06:45AM	Buying These Dirt-Cheap Stocks Could Be a Brilliant Move (Motley Fool)
05:50AM	A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now (Motley Fool)
05:43AM	2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips? (Motley Fool)
04:30AM	Will Pfizer Be a Trillion-Dollar Stock by 2035? (Motley Fool)
Mar-22-24 10:07PM	China Loosens Cross-Border Data Rules on Business Pressure (Bloomberg)
Mar-21-24 03:30PM	Key Acquisitions and AI Are Turning This Veteran Back Into a Competitor (InvestorPlace)
11:38AM	BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript (Insider Monkey)
11:31AM	OmniAb, Inc. (NASDAQ:OABI) Q4 2023 Earnings Call Transcript (Insider Monkey)
11:06AM	Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:35AM	12 Best 5% Dividend Stocks To Buy According To Hedge Funds (Insider Monkey)
07:30AM	Is Pfizer the Best Dividend Stock for You? (Motley Fool)
01:43AM	Q4 2023 BioNTech SE Earnings Call (Thomson Reuters StreetEvents)
Mar-20-24 05:51PM	15 Countries with the Highest Life Expectancy in Africa (Insider Monkey)
03:38PM	BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials (Benzinga)
02:32PM	BioNTech Tumbles as Q4 Profit, Sales Trail Estimates on Falling COVID-19 Vaccine Demand (Investopedia)
01:26PM	Top Stock Movers Now: Chipotle, Equinix, Signet Jewelers, and More (Investopedia)
10:34AM	BioNTech Earnings Miss Estimates. The Stock Falls and Also Drags Moderna Lower. (Barrons.com)
10:00AM	Pfizer Is Too Cheap to Ignore (GuruFocus.com)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts (Business Wire)
07:49AM	BioNTech Earnings Fall Short of Estimates. The Stock Is Down. (Barrons.com)
06:22AM	UPDATE 1-After earnings plunge, BioNTech pins hopes on cancer drug launches (Reuters)
06:15AM	After earnings plunge, BioNTech pins hopes on cancer drug launches (Reuters)
Mar-19-24 05:45PM	Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
12:19PM	Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale (The Wall Street Journal)
11:08AM	Pfizer (PFE) to Decrease Stake in Haleon From 32% to 24% (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOURLA ALBERT	Chairman & CEO	Feb 23 '24	Option Exercise	27.34	127,674	3,490,607	439,748	Feb 27 01:46 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23 '24	Option Exercise	27.34	95,755	2,617,942	230,920	Feb 27 01:46 PM
SUSMAN SALLY	Executive Vice President	Feb 23 '24	Option Exercise	27.34	63,837	1,745,304	218,148	Feb 27 01:46 PM
JOHNSON RADY A	Executive Vice President	Feb 23 '24	Option Exercise	27.34	29,436	804,780	123,073	Feb 27 01:46 PM
McDermott Michael	Executive Vice President	Feb 23 '24	Option Exercise	27.34	12,412	339,344	95,408	Feb 27 01:47 PM
SAHNI PAYAL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	11,527	315,148	34,604	Feb 27 01:46 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23 '24	Option Exercise	27.34	9,752	266,620	19,228	Feb 27 01:46 PM
BOSHOFF CHRISTOFFEL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	9,752	266,620	148,703	Feb 27 01:44 PM
Gottlieb Scott	Director	Dec 15 '23	Buy	26.47	3,000	79,401	9,000	Dec 19 09:31 AM
Gottlieb Scott	Director	May 08 '23	Buy	38.58	1,000	38,580	6,000	May 09 04:17 PM
Gottlieb Scott	Director	May 05 '23	Buy	38.42	1,000	38,425	5,000	May 09 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc.

Upgrade your FINVIZ experience